United States Oncology Regulatory Affairs Corporate Office — Nashville, Tennessee

United States Oncology Regulatory Affairs Corporate Office is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

United States Oncology Regulatory Affairs Corporate Office has participated in 9 clinical trials with 8 currently active.

Therapeutic areas: Solid Tumors, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States Oncology Regulatory Affairs Corporate Office?

United States Oncology Regulatory Affairs Corporate Office has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States Oncology Regulatory Affairs Corporate Office conducted?

United States Oncology Regulatory Affairs Corporate Office has 9 clinical trials on record, with 8 currently active. Their work covers Solid Tumors, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer.

Is United States Oncology Regulatory Affairs Corporate Office accredited by Crixeo Health?

United States Oncology Regulatory Affairs Corporate Office has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States Oncology Regulatory Affairs Corporate Office?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.